INVA as of Nov 1 · 10:19 ET
INVANasdaqPharmaceutical Preparations
Innoviva, Inc. · Brief
Next report
3 days
Nov 4 · after closeest.Q3 FY26
Expected move
Inputs1 of 8≥ implied
- avg implied
- ±10.5%
- avg realized
- ±3.0%
Nov 6 '24±11.0%▲+0.40%×0.04
Feb 26 '25±15.4%▼−1.96%×0.13
May 7 '25±22.9%▼−0.85%×0.04
Aug 6 '25±6.4%▲+1.15%×0.18
Q3 FY25±7.9%▲+12.89%×1.62
Q1 FY26±8.8%▼−2.89%×0.33
May 6 '26±6.2%▲+1.24%×0.20
Q2 FY26±5.8%▲+2.93%×0.51
quarterimplied−25%0+25%realized×
Q2 FY26±5.8%▲+2.93%×0.51
May '26±6.2%▲+1.24%×0.20
Q1 FY26±8.8%▼−2.89%×0.33
Q3 FY25±7.9%▲+12.89%×1.62
Aug '25±6.4%▲+1.15%×0.18
May '25±22.9%▼−0.85%×0.04
2 older reports
Feb '25±15.4%▼−1.96%×0.13
Nov '24±11.0%▲+0.40%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 4 report · est.Bull2
Bear2
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
INVA report sessionCustomers 1
× = co-movement · max 500dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.